SEC Filing Summary: BioSig Technologies, Inc. (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by BioSig Technologies, Inc. (not Streamex Corp.) on November 25, 2016, covering events that occurred on November 18, 2016. The filing reports the results of a Special Meeting of stockholders held to approve corporate governance amendments.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate actions and voting results rather than financial performance.
Material Changes and Corporate Actions
Stockholders approved two significant proposals at the Special Meeting:
- Equity Incentive Plan Amendment: Approved the Fifth Amendment to the 2012 Equity Incentive Plan, increasing the number of shares available for issuance by 3,500,000. The total shares available under the Plan are now 15,186,123.
- Authorized Share Increase: Approved an amendment to the Amended and Restated Certificate of Incorporation, increasing the number of authorized common shares from 50,000,000 to 200,000,000.
Voting Results and Management Commentary
The filing details the final voting results for the two proposals:
| Proposal | For | Against | Abstain | Broker Non-Votes |
|---|---|---|---|---|
| Fifth Plan Amendment (Equity) | 9,323,909 | 310,546 | 60,150 | 3,039,325 |
| Certificate Amendment (Authorized Shares) | 11,900,617 | 771,540 | 61,773 | N/A |
Management commentary is limited to the procedural approval of these amendments, which were previously approved by the Board of Directors on September 7, 2016. No specific risks, contingencies, or unusual financial items were disclosed in this filing.
Investor Verification Checklist
- Verify the impact of the 3.5 million share increase on the 2012 Equity Incentive Plan regarding potential future dilution.
- Confirm the filing of the Certificate Amendment with the Delaware Secretary of State to validate the new 200 million authorized share cap.
- Review the definitive proxy statement filed on October 24, 2016, for detailed rationale behind the amendments.
- Note the discrepancy between the requested company name (Streamex Corp.) and the actual registrant (BioSig Technologies, Inc.).